FEATURED NEWS

• HDA Statement on the President's Drug Affordability Executive Orders

  July 24, 2020

  In response to President Trump signing drug pricing Executive Orders (EOs), Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr. released the following statement.

• HDA Celebrates Manufacturers' New Product Introductions With 2020 DIANA Awards

  July 20, 2020

  The Healthcare Distribution Alliance (HDA) honored five pharmaceutical and consumer product manufacturers with the Distribution Industry Award for Notable Achievements in Healthcare (DIANA). Awardees were recognized in the “Best New Product Introductions or Promotions” categories. Annually presented at the Business and Leadership Conference (BLC), the awards were given virtually during the 2020 BLC Online.

• HDA Outlines Principles for Pandemic and Public Health Emergency Response

  June 11, 2020

  The Healthcare Distribution Alliance (HDA) released policy principles reaffirming the pharmaceutical distribution industry’s commitment to assisting the country and frontline healthcare providers during pandemics and public health emergencies.

• HDA Video Showcases Distributor COVID-19 Response Efforts

  May 20, 2020

  HDA released a two-minute video that further reinforces the pharmaceutical distribution industry’s critical function as it adapts and rises to the challenge of COVID-19, while also continuing the vital work of delivering the medicines Americans rely on to manage their daily healthcare needs.

• HDA Statement on “Project Airbridge” Initiative

  March 29, 2020

  Healthcare Distribution Alliance (HDA) President and CEO Chester “Chip” Davis, Jr., released the following statement regarding today’s White House Coronavirus Task Force briefing and the “Project Airbridge” initiative.